Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | NR3C2 | P08235 | 3/20 | 0.36 |
| ▸ | CNR1 | P21554 | 4/20 | 0.35 |
| ▸ | CNR2 | P34972 | 4/20 | 0.35 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24601403 | 0.94 | ESR1 (0.43) | ESR1ESR2ALDH1A1CYP3A4NR3C2 | |
| SCHEMBL24601398 | 0.94 | ESR1 (0.43) | ESR1ESR2ALDH1A1CYP3A4NR3C2 | |
| SCHEMBL24601399 | 0.93 | ESR1 (0.40) | ESR1ESR2ALDH1A1CYP3A4NR3C2 | |
| SCHEMBL24601405 | 0.91 | CNR1 (0.36) | ESR1ESR2ALDH1A1CYP3A4NR3C2 | |
| SCHEMBL24601425 | 0.87 | RXRA (0.35) | ESR1ESR2ALDH1A1CYP3A4NR3C2 | |
| SCHEMBL24601502 | 0.86 | RXRB (0.33) | ESR1ESR2ALDH1A1CYP3A4CNR1 | |
| SCHEMBL24601397 | 0.86 | CNR1 (0.38) | ESR1ESR2ALDH1A1CYP3A4NR3C2 | |
| SCHEMBL24601627 | 0.86 | HTR1D (0.35) | ALDH1A1KIF11 | |
| SCHEMBL24601401 | 0.86 | SERPINE1 (0.37) | ALDH1A1CNR1CNR2KIF11 | |
| SCHEMBL24601503 | 0.85 | ESR1 (0.38) | ESR1ESR2KIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220213113-A1 | NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220213113-A1 | NITROGEN-CONTAINING CONDENSED CYCLIC COMPOUNDS, FLUORESCENCE EMITTERS, ORGANIC ELECTROLUMINESCENT DEVICES, AND MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | NCL, NOC2L, NOLC1 | ESR1 1037/4885ESR2 2012/4885ALDH1A1 3824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.